Nuvalent, Inc. (NUVL)
NASDAQ: NUVL · Real-Time Price · USD
110.39
+1.12 (1.02%)
May 29, 2026, 4:00 PM EDT - Market closed
Nuvalent Market Cap
Nuvalent has a market cap or net worth of $8.72 billion as of May 29, 2026. Its market cap has increased by 71.00% in one year.
Market Cap
8.72B
Enterprise Value
7.43B
1-Year Change
71.00%
Ranking
Category
Stock Price
$110.39
Market Cap Chart
Since the IPO on July 29, 2021, Nuvalent's market cap has increased from $795.96M to $8.72B, an increase of 995.60%. That is a compound annual growth rate of 64.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 8.72B | 11.64% |
| Dec 31, 2025 | 7.81B | 40.44% |
| Dec 31, 2024 | 5.56B | 20.68% |
| Dec 29, 2023 | 4.61B | 174.21% |
| Dec 30, 2022 | 1.68B | 82.83% |
| Dec 31, 2021 | 919.33M | 15.50% |
| Jul 29, 2021 | 795.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioMarin Pharmaceutical | 11.07B |
| Arrowhead Pharmaceuticals | 10.97B |
| ABIVAX Société Anonyme | 10.56B |
| Cytokinetics | 10.42B |
| Praxis Precision Medicines | 9.76B |
| Krystal Biotech | 9.11B |
| Bio-Techne | 8.09B |
| Halozyme Therapeutics | 7.89B |